title: Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
authors.affiliation: Department of Nephrology, Hospital del Mar, Barcelona, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Puig
authors.forename: J
authors.initials: J
authors.lastname: Lloveras
authors.forename: P
authors.initials: P
authors.lastname: Fernández-Crespo
authors.forename: M
authors.initials: M
authors.lastname: Mir
authors.forename: V
authors.initials: V
authors.lastname: Iñigo
authors.forename: J M
authors.initials: JM
authors.lastname: Manresa
authors.forename: J
authors.initials: J
authors.lastname: Masramón
mesh_terms: D000208:Acute Disease; D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid